ArticleCost effectiveness and resource allocation : C/E2026

Cost-effectiveness analysis of molecular reflex testing-based targeted therapy in non-small cell lung cancer from a German healthcare payer perspective using a decision tree model.

Leonie Schumacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.